Synopsys today
As of 06/13/2025 04:00 pm
- 52 weeks
- $ 365.74
▼
624.80 dollars
- P/E ratio.
- 32.98
- The target price
- 607.14 dollars
Although only a small part of the attention of AI-CIP designers, synopsys is received Nasdak: snps It is a very important company for the semiconductor industry. SYNOPSys is necessary to develop these chips and many other chips, making it an important part of the industry to understand and possibly invest in it.
However, Synopsys shares have witnessed a recent disappointing performance. As of the closure of June 11, they are About 13 % decreased in the past 52 weeks. The recent news related to China and Trump does not help. So, what are the recent developments surrounding Synopsys? In addition, does this vital company still have the possibility to estimate stock prices in the long run?
Abstracts are hit as Trump closes EDA sales to China
On May 28, shares SYNOPSys has decreased by approximately 10 %. This was a reaction to the news that the Trump administration ordered the summaries and other EDA companies to stop sales to China. This will be far from the trivial loss of business. About 10 % of the company’s revenues came from China in the last quarter. The restriction emphasizes the importance of Synopsys in developing advanced chips. US government officials see China’s cutting off the Synopsys programs as a way to slow down the development of this technology.
This was a dark cloud attached to the strong financial results of the company, which appeared on the same day after the market was closed. The company won sales estimates and amended profits of the share (EPS). The numbers grew by 10 % and 22 % for the previous quarter of the previous year, respectively.
Synopsys said in the profit call that she had not received a notification of this restriction from the administration. However, this notification came the next day. This led the company to Suspended.
Although this restriction is definitely not good news of the summary, it is not also Backbreaker who may appear at first. The contribution of the company’s revenues from China decreased from 15 % in the fiscal year 2024 to 10 % in the last quarter. Now, geography is the smallest contributor to the five information technology reports.
Commercial restrictions on China are not new to the company. The growth of sales in the country was slowing down for years. This is because previous restrictions have shrunk the group of Chinese clients who can sell them.
This indicates that China was already a great work for summaries, and softening this new restriction. Another very important issue that must be addressed is the planned acquisition of Ansys Nasdaq: Anss.
ANSYS Approval gets a new wrist
Synopsys first Ansys Again in January 2024 for $ 35 billion. However, the company is still awaiting organizational approval of the deal. Chinese organizers remain the only group that has not yet agreed. There was some speculation that the deal could be approved sooner, because the company no longer does commercial business in China.
At the Bank of American Global Technology 2025 on June 4, the company noted that some have guaranteed that anonymal deal could be “this week”. However, this seems to require the company to decide that it no longer needs approval from China.
Synopsys has pushed the idea that she would look at this. Commercial negotiations between China and the United States can be offered in a way that regains the ability of Synopsys to sell in China. Movie the acquisition Without the approval of China, it can harm its opportunities to re -enter the Chinese market.
Therefore, Synopsys still seeks to obtain the necessary approval from China. This approval is expected to come in the first half of 2025. With new commercial restrictions, there is a possibility that China’s position on the deal will crucify. You can try to use it as a bargaining anti -negotiation.
SNPS: Uncertainty in the short term, but secular trends are very large to ignore them
SYNOPSys today
607.14 dollars
26.79 % upModerate purchase
Based on 13 analyst classifications
| The current price | 478.86 dollars |
|---|---|
| High expectations | $ 685.00 |
| Average prediction | 607.14 dollars |
| Low expectations | $ 520.00 |
Expected details of Synopsys shares
Since Synopsys hung its directives, Keycorp analysts set a $ 540 on the arrow. This means 8 % compared to the closing price on June 11. This indicates a very moderate amount The budget capabilitiesThe ANSYS deal provides the opposite wind in the near -term.
However, the company’s long -term prospects are still strong. Ansys is likely to pass, which will greatly help the company’s competitive position.
In addition, the company will benefit from the recovery in the unprecedented markets that have witnessed a decrease in some time now.
In general, the secular trend in developing more and more advanced chips across the final markets puts stocks Long -term success.
Before you think about Synopsys, you will want to hear this.
Marketbeat follows the best research analyst at Wall Street, the best performance in Wall Street and the stocks they recommend to their customers on a daily basis. Marketbeat has selected the five shares whose senior analysts are quietly whispered to their customers to buy now before hunting the broader market … and Synopsys was not in the list.
While Synopsys currently has a moderate purchase classification between analysts, higher -rated analysts believe that these five stocks buy better.
Show the five stocks here
Marketbeat has released a list of 10 cheap shares that have been ignored by the market and may be dangerously denied its value. Enter your email address and add to know the companies that set the list.
